Shop
Norditropin NordiFlex 5 mg / 1.5 ml injection
Norditropin NordiFlex 5mg/1.5ml Injection is a recombinant human growth hormone (Somatropin) used to treat growth hormone deficiency (GHD) in children and adults. It stimulates growth, increases height in children with GHD, and helps improve body composition in adults by promoting lean muscle mass and reducing body fat.
The NordiFlex device is a pre-filled, ready-to-use injection pen that ensures accurate dosing and easy self-administration. Each pen contains 5mg of Somatropin in 1.5ml solution. The injection is administered subcutaneously and is typically used once daily, as per the physician’s instructions.
Norditropin is indicated for:
Pediatric patients with growth failure due to GHD, Turner syndrome, Noonan syndrome, or chronic renal insufficiency.
Adults with adult-onset or childhood-onset GHD.
Children born small for gestational age (SGA) who fail to catch up in growth.
Administration should follow a tailored dosage regimen determined by your doctor based on weight, age, and therapeutic goals. Proper rotation of injection sites (thigh, abdomen) helps prevent lipodystrophy.
Possible side effects include injection site reactions, joint pain, muscle pain, edema, and headaches. Serious adverse effects like intracranial hypertension or glucose metabolism disorders are rare but require immediate medical attention.
Store the NordiFlex pen in a refrigerator at 2°C to 8°C. Once in use, it can be stored at room temperature (up to 25°C) for up to 21 days.
Novomix 30 Flexpen 3ml 5’s
NovoMix 30 FlexPen (Insulin Aspart Biphasic 100IU/mL) is a premixed insulin formulation used for managing Type 1 and Type 2 Diabetes Mellitus. It combines 30% rapid-acting Insulin Aspart with 70% intermediate-acting protamine-crystallized Insulin Aspart, providing both immediate and prolonged blood sugar control.
Each pack contains 5 pre-filled FlexPens, with each pen holding 3ml of insulin (100IU/mL). The FlexPen device is user-friendly, offering accurate dosing and convenient on-the-go insulin administration. NovoMix 30 is designed to cover mealtime glucose spikes and maintain basal insulin levels throughout the day.
Patients typically administer NovoMix 30 subcutaneously before meals, with dosing frequency determined by individual blood glucose monitoring and physician recommendations. The pen allows for easy and precise dose adjustments to ensure effective glycemic control.
NovoMix 30 FlexPen provides:
Rapid onset of action (within 10-20 minutes)
Peak effect at 1-4 hours
Duration of action up to 24 hours
Common injection sites include the abdomen, thighs, or upper arms. Rotation of injection sites helps minimize the risk of lipodystrophy.
Possible side effects include hypoglycemia, local injection site reactions, and mild weight gain. Patients should monitor blood glucose regularly and carry a source of fast-acting sugar to treat potential hypoglycemia.
Unopened FlexPens should be stored in a refrigerator at 2°C to 8°C. Once in use, the pen can be kept at room temperature (below 30°C) for up to 28 days.
NovoRapid Flexpen 100 U/ml 5x3ml
₨ 5,000Product Specification
| Packaging Size | 5x3ml |
| Brand | NovoRapid Flexpen 100 U/ml |
| Composition | Insulin Aspart (100IU) |
| Manufacturer | Novo Nordisk |
| treatment | Diabetes Mellitus |
